Tibet Weixinkang Medicine Co., Ltd.
SHH: 603676.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yong Zhang
- Employees
- 689
- Headquarters
- Lhasa, China
- IPO year
- 2017
- Market cap
- CN¥4.5B
- Website
- https://www.wxkpharma.com
Loading 603676…
Loading profile data…Frequently asked questions about 603676
What does Tibet Weixinkang Medicine Co., Ltd. (603676.SS) do?
Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company's products include parenteral nutrition vitamins, electrolyte supplements, intravenous iron supplements, antibiotics, and medicine for digestive system and liver diseases. It also offers injection mul...
Where does 603676.SS trade?
Tibet Weixinkang Medicine Co., Ltd. (603676.SS) trades on the Shanghai Stock Exchange.
What sector is 603676.SS in?
Tibet Weixinkang Medicine Co., Ltd. (603676.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Tibet Weixinkang Medicine Co., Ltd.?
Yong Zhang is the chief executive officer of Tibet Weixinkang Medicine Co., Ltd. (603676.SS).
Where is Tibet Weixinkang Medicine Co., Ltd. headquartered?
Tibet Weixinkang Medicine Co., Ltd. is headquartered in China.
Does 603676.SS pay a dividend?
Yes — Tibet Weixinkang Medicine Co., Ltd. (603676.SS) paid a trailing twelve-month dividend of CNY 0.33 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603676.SS go public?
Tibet Weixinkang Medicine Co., Ltd. (603676.SS) completed its initial public offering in 2017.